June 14, 2023
Kentucky & Ohio Joint Open Public Draft/Revised LCD Discussion Meeting: July 11, 2023
CGS will host a Joint Kentucky & Ohio Open Meeting both onsite and via Microsoft Teams for comments from providers and the general public related to the development and or revision of Local Coverage Determinations (LCDs) for Medicare Jurisdiction15.
Date: |
July 11th, 2023 |
Time: |
4:00-5:00 p.m. ET (3:00-5:00 CT) |
Place: |
Onsite: For those unable to attend in person, the meeting will also be available via Microsoft Teams. To attend virtually you must register here. |
Please note that this is the Open Public meeting to discuss Draft LCDs or Revisions to current LCDs and not the Contractor Advisory Committee Meetings (CAC).
The following draft LCD(s) will be discussed:
- DL39575 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- DA59374 - Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- DL38378 Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
- DA59374 - Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- DL39585 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- DA59382 - Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- DL37578 Micro-Invasive Glaucoma Surgery (MIGS)
- DA59382 - Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
Link to the Draft LCDs: Kentucky Proposed/Draft LCDs Not Released to Final
Link to the Draft LCDs: Ohio Proposed/Draft LCDs Not Released to Final
Interested parties who wish to make presentations related to the draft LCD must submit a written request, no later than 6/27/2023 to CMD.Inquiry@cgsadmin.com and include the following information:
- Name, address, telephone number and e-mail address of presenter
- Name, address, telephone number and e-mail address of organization
- Name of draft LCD
- Copy of the presentation(s)
- Completed Conflict of Interest (COI) Form for each topic you wish to present.
- DL39575/ DA59374 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- DL38378/ DA57926 Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
- DL39585/DA59382 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- DL37578/DA56491 Micro-Invasive Glaucoma Surgery (MIGS)
The presentation and COI form must be attached to your request(s). Each presenter will have equal time based on the number of presentations requested. Once all requests are received, we will notify each presenter of the time allocation via email approximately one week prior to the meeting.
Future Meetings
Onsite meetings are tentative and could be changed to joint teleconference/webinar.
- Onsite Kentucky Meeting 11/07/2023
- Onsite Ohio Meeting 11/08/2023